European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
J. Head. Pain; 20 (6), 2019
BACKGROUND AND AIM:
Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...
Migraine Disorders, Migraine Disorders/diagnosis, Migraine Disorders/drug therapy, Migraine Disorders/therapy, Migraine Disorders/prevention & control, Receptors, Calcitonin Gene-Related Peptide/therapeutic use, Calcitonin Gene-Related Peptide/therapeutic use, Headache, Headache/drug therapy, Headache/diagnosis, Headache/therapy, Headache/prevention & control